StonvexLoading…
StonvexStonvexStonvexCore line items from ENZN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2024 2024-12-31 | Annual 2022 2022-12-31 | Annual 2021 2021-12-31 | Annual 2020 2020-12-31 |
|---|---|---|---|---|
Revenue | $26.00K | $26.00K | $701.00K | $52.00K |
Operating Income | $-1.33M | $-1.03M | $-469.00K | $-1.30M |
Net Income | $778.00K | $-186.00K | $-469.00K | $-1.31M |
EPS (Diluted) | $-0.01 | $-0.02 | $-0.03 | $-0.03 |
Total Assets | $47.17M | $47.59M | $47.75M | $48.23M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $46.86M | $46.98M | $47.64M | $48.14M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 74.21M | 74.21M | 74.21M | 74.21M |